Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

Mostrar otras versiones (1)

BACKGROUND: Testicular cancer patients have an increased risk for cardiovascular disease (CVD), which might be related to the increased prevalence of the metabolic syndrome (MetS) in this group of patients. METHODS: We assessed the prevalence of MetS and calculated the 10-year CVD risk in a cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales: Willemse, P M, Burggraaf, J, Hamdy, N A T, Weijl, N I, Vossen, C Y, van Wulften, L, van Steijn-van Tol, A Q M J, Rosendaal, F R, Osanto, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708554/
https://www.ncbi.nlm.nih.gov/pubmed/23660945
http://dx.doi.org/10.1038/bjc.2013.226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708554/
https://www.ncbi.nlm.nih.gov/pubmed/23660945
http://dx.doi.org/10.1038/bjc.2013.226

Ejemplares similares